You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 295 No. 2, January 11, 2006 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Pacemakers/ Defibrillators
 •Cardiovascular System
 •Quality of Care
 •Quality of Care, Other
 •Cardiovascular Intervention
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Malfunctions of Implantable Cardioverter Defibrillators—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: Dr Levine and Mr Kohanyi state that with regard to the St Jude Medical Trilogy pacemaker advisory, "the failure rate based on our analysis of returned devices was not underestimated." As stated in the Commentary, it is often difficult to estimate the true incidence of an observed malfunction. The data from Levine's own editorial1 regarding the St Jude Medical Trilogy pacemaker advisory were accurately cited in the Commentary as an example of this difficulty.

It is instructive to review the Trilogy example in detail as outlined in a US Food and Drug Administration (FDA) investigation in response to a patient complaint.2-3 St Jude Medical became aware of the Trilogy problem in early 1997 via analysis of explanted field returns.3 By October 1998, the manufacturer understood the problem and validated a fix and a month later the FDA approved the proposed remedy.3 St Jude Medical implemented the fix in . . . [Full Text of this Article]

William H. Maisel, MD, MPH
wmaisel@bidmc.harvard.edu
Cardiovascular Division
Beth Israel Deaconess Medical Center
Harvard Medical School
Boston, Mass



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Malfunctions of Implantable Cardioverter Defibrillators
Paul A. Levine and Gabriel Kohanyi
JAMA. 2006;295(2):161.
EXTRACT | FULL TEXT  

Safety Issues Involving Medical Devices: Implications of Recent Implantable Cardioverter-Defibrillator Malfunctions
William H. Maisel
JAMA. 2005;294(8):955-958.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.